Characterization of nodular neuronal heterotopia in children

Brain

Volumn 122, Issue 2, 1999, Pages 219-238

  Hannan, Anthony J ^a   Servotte, Sandrine ^a   Katsnelson, Alia ^a   Sisodiya, Sanjay ^b,d   Blakemore, Colin ^a   Squier, Marian ^b   Molnár, Zoltán ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Calretinin; Cortex; Epilepsy; Heterotopia; Neuropeptide Y

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CALRETININ; CARBOCYANINE; NEUROPEPTIDE Y;

ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN INJURY; CASE REPORT; CELL MATURATION; CELL MIGRATION; CELL TYPE; CHILD; CONTROLLED STUDY; DYSPLASIA; FEMALE; GESTATIONAL AGE; HEMISPHERECTOMY; HETEROTOPIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; INTERNEURON; INTRACTABLE EPILEPSY; MALE; MICROGYRIA; NERVE CELL DIFFERENTIATION; NERVE CELL STIMULATION; NEWBORN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032901593     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.2.219     Document Type: Article

References (53)

1. Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 1997; 17: 8927-6.
2. Barkovich AJ, Kjos BO. Gray matter heterotopias: MR characteristics and correlation with developmental and neurologic manifestations. Radiology 1992; 182: 493-9.
3. Barkovich AJ, Kuzniecky RI. Neuroimaging of focal malformations of cortical development. [Review]. J. Clin Neurophysiol 1996; 13: 481-94.
4. Battaglia G, Arcelli P, Granata T, Selvaggio M, Andermann F, Dubeau F, et al. Neuronal migration disorders and epilepsy: a morphological analysis of three surgically treated patients. Epilepsy Res 1996; 26: 49-58.
5. A, NMDA and AMPA receptors: a developmentally regulated 'menage a trois'. [Review]. Trends Neurosci 1997; 20: 523-9.
6. Buhl EH, Otis TS, Mody I. Zinc-induced collapse of augmented inhibition by GABA in atemporal lobe epilepsy model. Science 1996; 271: 369-73.
7. del Rio MR, DeFelipe J. Colocalization of calbindin D-28k, calretinin, and GABA immunoreactivities in neurons of the human temporal cortex. J Comp Neurol 1996; 369: 472-82.
8. del Rio MR, DeFelipe J. Synaptic connections of calretinin-immunoreactive neurons in the human neocortex. J Neurosci 1997; 17: 5143-54.
9. Dobyns WB, Andermann E, Andermann F, Czapansky-Beilman D, Dubeau F, Dulac O, et al. X-linked malformations of neuronal migration. [Review]. Neurology 1996; 47: 331-9.
10. Dubeau F, Tampieri D, Lee N, Andermann E, Carpenter S, Leblanc R, et al. Periventricular and subcortical nodular heterotopia: a study of 33 patients. Brain 1995; 118: 1273-87.
11. Duncan JS, Panayiotopoulos CP, editors. Typical absences and related epileptic syndromes. London: Churchill Communications Europe; 1995.
12. Duong T, De Rosa MJ, Poukens V, Vinters HV, Fisher RS. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol (Berl) 1994; 87: 493-503.
13. Eksioglu YZ, Scheffer IE, Cardenas P, Knoll J, DiMario F, Ramsby G, et al. Periventricular heterotopia: an X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron 1996; 16: 77-87.
14. Farrell MA, De Rosa MJ, Curran JG, Lenard Secor D, Cornford ME, Comair YG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol (Berl) 1992; 83: 246-59.
15. Ferrer I, Catala I. Unlayered polymicrogyria: structural and developmental aspects. Anat Embryol (Berl) 1991; 184: 517-28.
16. Ferrer I, Pineda M, Tallada M, Oliver B, Russi A, Oiler L, et al. Abnormal local-circuit neurons in epilepsia partialis continua associated with focal cortical dysplasia. Acta Neuropathol (Berl) 1992; 83: 647-52.
17. Fink JM, Dobyns WB, Guerrini R, Hirsch BA. Identification of a duplication of Xq28 associated with bilateral periventricular nodular heterotopia. Am J Hum Genet 1997; 61: 379-87.
18. Flint AC, Kriegstein AR. Mechanisms underlying neuronal migration disorders and epilepsy. [Review]. Curr Opin Neurol 1997; 10: 92-7.
19. Francione S, Kahane P, Tassi L, Hoffmann D, Durisotti C, Pasquier B, et al. Stereo-EEG of interictal and ictal electrical activity of a historically proved heterotopic gray matter associated with partial epilepsy. Electroencephalogr Clin Neurophysiol 1994; 90: 284-90.
20. Godement P, Vanselow J, Thanos S, Bonhoeffer F. A study in developing visual systems with a new method of staining neurones and their processes in fixed tissue. Development 1987; 101: 697-713.
21. Hatazawa J, Sasajima T, Shimosegawa E, Fujita H, Okudera T, Kanno I, et al. Regional cerebral blood flow response in gray matter heterotopia during finger tapping: an activation study with positron emission tomography. AJNR Am J Neuroradiol 1996; 17: 479-82.
22. Hendry SH, Jones EG, Emson PC, Lawson DE, Heizmann CW, Streit P. Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp Brain Res 1989; 76: 467-72.
23. Hornung JP, De Tribolet N Chemical organization of the human cerebral cortex. In: Tracey DJ, Paxinos G, Stone J, editors. Neurotransmitters in the human brain. New York: Plenum Press; 1995. p. 41-5.
24. Hornung JP, De Tribolet N, Tork I. Morphology and distribution of neuropeptide-containing neurons in human cerebral cortex. Neuroscience 1992; 51: 363-75.
25. Huttenlocher PR, Taravath S, Mojtahedi S. Periventricular heterotopia and epilepsy. Neurology 1994; 44: 51-5.
26. Jensen KF, Killackey HP. Subcortical projections from ectopic neocortical neurons. Proc Natl Acad Sci USA 1984; 81: 964-8.
27. Kisvarday ZF, Gulyas A, Beroukas D, North JB, Chubb IW, Somogyi P. Synapses, axonal and dendritic patterns of GABA-immunoreactive neurons in human cerebral cortex. [Review]. Brain 1990; 113: 793-812.
28. Kuzniecky RI. MRI in cerebral developmental malformations and epilepsy. [Review]. Magn Reson Imaging 1995; 13: 1137-45.
29. Lee N, Radtke RA, Gray L, Burger PC, Montine TJ, DeLong GR, et al. Neuronal migration disorders: positron emission tomography correlations. Ann Neurol 1994; 35: 290-7.
30. Li LM, Fish DR, Sisodiya SM, Shorvon SD, Alsanjari N, Stevens JM. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry 1995; 59: 384-7.
31. Li LM, Dubeau F, Andermann F, Fish DR, Watson C, Cascino GD, et al. Periventricular nodular heterotopia and intractable temporal lobe epilepsy: poor outcome after temporal lobe resection. Ann Neurol 1997; 41: 662-8.
32. Manz HJ, Phillips TM, Rowden G, McCullough DC. Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (Berl) 1979; 45: 97-103.
33. Marco P, Sola RG, Pulido P, Alijarde MT, Sanchez A, Ramon y Cajal S, et al. Inhibitory neurons in the human epileptogenic temporal neocortex: an immunocytochemical study. Brain 1996; 119: 1327-47.
34. Marsh L, Lim KO, Sullivan EV, Lane B, Spielman D. Proton magnetic resonance spectroscopy of a gray matter heterotopia. Neurology 1996; 47: 1571-4.
35. Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995; 45: 1391-5.
36. Meencke HJ, Janz D. Neuropathological findings in primary generalized epilepsy: a study of eight cases. Epilepsia 1984; 25: 8-21.
37. Mirkovic N, Hannan AJ, Blakemore C, Streit P, Sisodiya S, Squier M, et al. Further characterization of neuronal heterotopia in children with epilepsy. Suppl Euro J Neurosci 1998; 10: 50.
38. Musumeci SA, Ferri R, Elia M, Scuderi C, Del Gracco S, Azan G, et al. A new family with periventricular nodular heterotopia and peculiar dysmorphic features: a probable X-linked dominant trait, Arch Neurol 1997; 54: 61-4.
39. Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y, Andermann E, et al. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. [Review]. Ann Neurol 1991; 30: 741-9.
40. Palmini A, Andermann F, Tampieri D, Andermann E, Robitaille Y, Olivier A. Epilepsy and cortical cytoarchitectonic abnormalities: an attempt at correlating basic mechanisms with anatomoclinical syndromes. Epilepsy Res Suppl 1992; 9: 19-29.
41. Palmini A, Gambardella A, Andermann F, Dubeau F, da Costa JC, Olivier A, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995; 37: 476-87.
42. Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996; 47: 1567-71.
43. Raymond AA, Fish DR, Stevens JM, Sisodiya SM, Alsanjari N, Shorvon SD. Subependymal heterotopia: a distinct neuronal migration disorder associated with epilepsy. [Review]. J Neurol Neurosurg Psychiatry 1994; 57: 1195-202.
44. Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM, Shorvon SD. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy - clinical, EEG and neuroimaging features in 100 adult patients. [Review]. Brain 1995; 118: 629-60.
45. Sisodiya SM, Free SL, Stevens JM, Fish DR, Shorvon SD. Widespread cerebral structural changes in patients with cortical dysgenesis and epilepsy. Brain 1995; 118: 1039-50.
46. Sorvari H, Soininen H, Pitkanen A. Calretinin-immunoreactive cells and fibers in the human amygdaloid complex. J Comp Neurol 1996; 369: 188-208.
47. Spreafico R, Battaglia G, Arcelli P, Andermann F, Dubeau F, Palmini A, et al. Cortical dysplasia: an immunocytochemical study of three patients [see comments]. Neurology 1998; 50: 27-36. Comment in: Neurology 1998; 50: 8-10.
48. Spreafico R, Battaglia G, Arcelli P, Andermann F, Dubeau F, Palmini A, et al. Cortical dysplasia: an immunocytochemical study of three patients [see comments]. Neurology 1998; 50: 27-36. Comment in: Neurology 1998; 50: 8-10.
49. Taylor DC, Falconer MA, Bruton CJ, Corsellis J. A. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971; 34: 369-87.
50. Woldbye DP, Larsen PJ, Mikkelsen JD, Klemp K, Madsen TM, Bolwig TG. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors [see comments]. Nat Med 1997; 3: 761-4. Comment in: Nat Med 1997; 3: 728-9.
51. Woldbye DP, Larsen PJ, Mikkelsen JD, Klemp K, Madsen TM, Bolwig TG. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors [see comments]. Nat Med 1997; 3: 761-4. Comment in: Nat Med 1997; 3: 728-9.
52. Wolff JR, Bottcher H, Zetzsche T, Oertel WH, Chronwall BM. Development of GABAergic neurons in rat visual cortex as identified by glutamate decarboxylase-like immunoreactivity. Neurosci Lett 1984; 47: 207-12.
53. Ying Z, Babb TL, Comair YG, Bingaman W, Bushey M, Touhalisky K. Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. J Neuropathol Exp Neurol 1998; 57: 47-62.